Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2023.01.002Source: DataRank Database

The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy is a research paper published in Journal of the American Academy of Dermatology (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.46)OA: bronzeTopics (23)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ryland D. Mortlock ORCID,Jolanta Pach ORCID,Jeffrey M. Cohen ORCID,Jonathan S. Leventhal ORCID,Annika Belzer ORCID

Live enrichment

PubMed:36634749 PMC:PMC10121758 OpenAlex:https://openalex.org/W4313887696

NIGMS NIH HHS

Grant: T32 GM136651

NCATS NIH HHS

Grant: UL1 TR001863

NIH

FWCI

0.46

Citation Percentile

0.6%

Citation Trend

2023

2024

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jaad.org/article/S0190962223000609/pdf

publisherhttp://www.jaad.org/article/S0190962223000609/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0190962223000609?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0190962223000609?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaad.2023.01.002

Fields of Study

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways

MeSH Terms

Immune Checkpoint InhibitorsAdministration, CutaneousEczemaHumansNeoplasmsPsoriasisRetrospective StudiesSkin

Keywords

MedicinePsoriasisAdverse effectImmune systemDermatologyImmunologyInternal medicineEczemaOncodermatologyImmunotherapy (Io)Immune Checkpoint Inhibitor (Ici)Cutaneous Immune-related Adverse Event (Cirae)

Sustainable Development Goals

SDG 0: Good health and well-being